Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Robertson

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
British Dental Journal|January 26, 2020
The use of silver diamine fluoride (SDF) in dental practiceNassar Seifo, Mark Robertson, Jeanette MacLean, et al.
Journal of Dentistry|June 3, 2018
Cost-effectiveness of managing cavitated primary molar caries lesions: A randomized trial in GermanyFalk Schwendicke, Joachim Krois, Christian H Splieth, et al.
Cardiology in the Young|July 8, 2011
Follow-up of tetralogy of Fallot patients: tertiary centre versus satellite clinicCamille L Hancock Friesen, Mark Robertson, David Liu, et al.
Cancer Research|May 19, 2023
Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling DynamicsJill Gallaher, Maximilian Strobl, Jeffrey West, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Evolutionary antifragile therapyJeffrey West, Bina Desai, Maximilian Strobl, et al.
Scientific Reports|November 24, 2017
Systematic Screening of Chemokines to Identify Candidates to Model and Create Ectopic Lymph Node Structures for Cancer ImmunotherapyYohsuke Yagawa, Mark Robertson-Tessi, Susan L Zhou, et al.
Cancer Research|September 16, 2020
Searching for Goldilocks: How Evolution and Ecology Can Help Uncover More Effective Patient-Specific ChemotherapiesDerek S Park, Kimberly A Luddy, Mark Robertson-Tessi, et al.
Communications Medicine|May 23, 2022
Spatial structure impacts adaptive therapy by shaping intra-tumoral competitionMaximilian A R Strobl, Jill Gallaher, Jeffrey West, et al.
Frontiers in Immunology|March 1, 2024
Tumor-immune metaphenotypes orchestrate an evolutionary bottleneck that promotes metabolic transformationJeffrey West, Frederika Rentzeperis, Casey Adam, et al.
Cancer Research|May 22, 2026
Evolutionary antifragile therapy is a treatment strategy to suppress drug resistance by exploiting dose response convexityJeffrey West, Bina Desai, Maximilian A R Strobl, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
British Dental Journal|January 26, 2020
The use of silver diamine fluoride (SDF) in dental practiceNassar Seifo, Mark Robertson, Jeanette MacLean, et al.
Journal of Dentistry|June 3, 2018
Cost-effectiveness of managing cavitated primary molar caries lesions: A randomized trial in GermanyFalk Schwendicke, Joachim Krois, Christian H Splieth, et al.
Cardiology in the Young|July 8, 2011
Follow-up of tetralogy of Fallot patients: tertiary centre versus satellite clinicCamille L Hancock Friesen, Mark Robertson, David Liu, et al.
Cancer Research|May 19, 2023
Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling DynamicsJill Gallaher, Maximilian Strobl, Jeffrey West, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Evolutionary antifragile therapyJeffrey West, Bina Desai, Maximilian Strobl, et al.
Scientific Reports|November 24, 2017
Systematic Screening of Chemokines to Identify Candidates to Model and Create Ectopic Lymph Node Structures for Cancer ImmunotherapyYohsuke Yagawa, Mark Robertson-Tessi, Susan L Zhou, et al.
Cancer Research|September 16, 2020
Searching for Goldilocks: How Evolution and Ecology Can Help Uncover More Effective Patient-Specific ChemotherapiesDerek S Park, Kimberly A Luddy, Mark Robertson-Tessi, et al.
Communications Medicine|May 23, 2022
Spatial structure impacts adaptive therapy by shaping intra-tumoral competitionMaximilian A R Strobl, Jill Gallaher, Jeffrey West, et al.
Frontiers in Immunology|March 1, 2024
Tumor-immune metaphenotypes orchestrate an evolutionary bottleneck that promotes metabolic transformationJeffrey West, Frederika Rentzeperis, Casey Adam, et al.
Cancer Research|May 22, 2026
Evolutionary antifragile therapy is a treatment strategy to suppress drug resistance by exploiting dose response convexityJeffrey West, Bina Desai, Maximilian A R Strobl, et al.
Pageof 10